Pfizer Recalls Zithromax Injection Lots for Impurity Specification Failures
Pfizer is recalling specific lots of Zithromax (azithromycin) injection due to out-of-specification results for a degradant.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class III recall, which indicates a remote possibility of adverse health consequences. The issue is a chemical impurity (degradant) rather than a high-risk pathogen or structural defect, and no injuries or illnesses are reported in the source text.
Plain-English summary
Pfizer Inc. is recalling certain lots of Zithromax (azithromycin dihydrate) for injection, 500 mg/vial. The recall involves 101,681 vials distributed nationwide and in Puerto Rico. The affected lots are identified by specific lot numbers and expiration dates, including G81845, 0B0CJ, G44710, G65241, G80003, G82722, G93028, G95309, and G97641.
The recall was initiated because the product failed impurities and degradation specifications. Specifically, the lots showed out-of-specification results for the azithromycin N-oxide degradant. This is a chemical byproduct that can form during the degradation of the active ingredient.
Healthcare providers and patients should check their inventory of Zithromax for injection against the listed lot numbers and expiration dates. If the product matches the recalled lots, it should not be used. Consumers and healthcare professionals should contact Pfizer or their local FDA office for further instructions on how to return or dispose of the affected medication.
The recalled product
- Product
- ZITHROMAX (AZITHROMYCIN DIHYDRATE)
- Brand
- ZITHROMAX
- Manufacturer
- Pfizer Inc.
- Category
- Drug — Antibiotic Injection
- Hazard
- Affected units
- 101,681
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot Number/Expiration Date G81845
- Exp 10/03/14 0B0CJ
- Exp 02/06/15 G44710
- Exp 07/10/15 G65241
- Exp 07/11/15 G80003
- Exp 10/17/15 G82722
- Exp 11/27/15 G93028
- G95309
- Exp: 01/23/16 G97641
- Exp 01/30/16
Distribution
Related recalls
Same manufacturer · Pfizer Inc.
See all →- HighSodium bicarbonate injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighEpinephrine injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighBicillin L-A 2.4 million unit vials recalled after particulates found
FDA (Drugs) · 2025-08-06
- HighBicillin L-A penicillin vials recalled after particulates found during visual inspection
FDA (Drugs) · 2025-08-06
- ModerateDobutamine Injection Recall Due to Discoloration and Cracked Vials
FDA (Drugs) · 2025-07-02
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17